ReviewMolecular diagnosis & therapy2019

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases.

Panayiota Papasavva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.